This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Rachael Lewus: Innovator in Antibody Formulations
Introduction
Rachael Lewus is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. Her work is vital in advancing therapeutic options for various medical conditions.
Latest Patents
Rachael holds a patent for "Stable, Aqueous Formulations of Antibodies that Bind IL5 Receptor." This innovative formulation is crucial for enhancing the stability and efficacy of antibody-based therapies.
Career Highlights
Rachael is currently employed at AstraZeneca AB, where she continues to push the boundaries of scientific research and development. Her expertise in antibody formulations has positioned her as a key player in the biotechnology industry.
Collaborations
Rachael collaborates with talented professionals, including Kelcy Newell and Kevin Douglas Stewart. These partnerships enhance her research and contribute to the success of her projects.
Conclusion
Rachael Lewus is a dedicated inventor whose work in antibody formulations is making a significant impact in the field of biotechnology. Her contributions are paving the way for innovative therapeutic solutions.